Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms
Metformin treatment of mice (Fig
Notably, individuals in Tyde Wellness have reported an average body weight reduction of 15% after 68 weeks, underscoring the efficacy of these treatments
Tang H, Lu Y, Donahoo WT, Shao H, Shi L, Fonseca VA, et al
In our respective medical societies, we may have opportunities to help advocate for better access
While GLP-1 receptor agonists (such as semaglutide and liraglutide) have demonstrated significant benefits in diabetes management, weight reduction, and cardiovascular outcomes in clinical trials, enhancing physiological GLP-1 through dietary and lifestyle modifications represents a foundational approach